Adherence to omalizumab: A multicenter "real-world" study-Reference-Cited by-同舟云学术

Adherence to omalizumab: A multicenter "real-world" study

Published:2020-02 Issue:2 Volume:13 Page:100103
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Campisi Raffaele,Crimi Claudia,Intravaia Rossella,Strano Simona,Noto Alberto,Foschino Maria Pia,Valenti Giuseppe,Viviano Vittorio,Pelaia Corrado,Ricciardi Luisa,Scichilone Nicola,Crimi Nunzio

Funder

Novartis Farma spa

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference32 articles.

1. Adherence to medication;Osterberg;N Engl J Med,2005

2. Drop-out rate among patients treated with omalizumab for severe asthma: literature review and real-life experience;Caminati;BMC Pulm Med,2016

3. World Health Organization (WHO). Adherence to long-term therapies: evidence for action. Dis specific Rev. http://www.who.int/chp/knowledge/publications/adherence_section3.pdf. Accessed June 18, 2013.

4. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires;Bender;Immunol Allergy Clin,2005

5. Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population;Broder;Allergy Asthma Proc,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive model to differentiate chronic histaminergic angioedema and chronic spontaneous urticaria with angioedema;Journal of Allergy and Clinical Immunology: Global;2024-08

2. Type 2 severe asthma: pathophysiology and treatment with biologics;Expert Review of Respiratory Medicine;2024-07-02

3. An Overview of Adherence—What It Is and Why It Is Important;The Journal of Allergy and Clinical Immunology: In Practice;2024-07

4. Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?;Pragmatic and Observational Research;2024-03

5. Omalizumab as a long-term treatment for patients with severe asthma. Is it safe?: A ten-year study;The Egyptian Journal of Chest Diseases and Tuberculosis;2024-01